AT Bancorp’s Exelixis EXEL Stock Holding History

AT Bancorp’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-25,733	Closed	-$456K	–	224
2018 Q3	$456K	Buy	25,733 +5,784	+29%	+$113K	0.05%	164
2018 Q2	$430K	Buy	+19,949	New	+$413K	0.05%	168

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AT Bancorp's EXEL Position: Q4 2018 in Review

AT Bancorp sold out of Exelixis (EXEL) in Q4 2018, closing a stake of 25,733 shares — an estimated $456K sold.

AT Bancorp first reported a position in EXEL in Q2 2018 and held it in 2 quarters. The position peaked at $456K in Q3 2018. 344 funds tracked by Wall St. Rank hold EXEL as of Q4 2018.

AT Bancorp reported no remaining Exelixis position as of Q4 2018 after selling out during the quarter.
AT Bancorp sold 25,733 Exelixis shares in Q4 2018, an estimated $456K.
AT Bancorp first reported a position in Exelixis in Q2 2018 and held it in 2 quarters.
AT Bancorp's Exelixis position peaked at $456K in Q3 2018.
344 funds tracked by Wall St. Rank held Exelixis as of Q4 2018.

Based on AT Bancorp's 13F filing for Q4 2018, filed 14 Feb 2019.